A detailed history of Seven Eight Capital, LP transactions in Avantor, Inc. stock. As of the latest transaction made, Seven Eight Capital, LP holds 30,295 shares of AVTR stock, worth $696,482. This represents 0.07% of its overall portfolio holdings.

Number of Shares
30,295
Holding current value
$696,482
% of portfolio
0.07%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$21.2 - $25.87 $642,254 - $783,731
30,295 New
30,295 $642,000
Q1 2023

May 12, 2023

BUY
$20.07 - $25.1 $975,703 - $1.22 Million
48,615 New
48,615 $1.03 Million
Q2 2022

Aug 04, 2022

SELL
$29.35 - $34.19 $1.77 Million - $2.06 Million
-60,224 Closed
0 $0
Q1 2022

May 11, 2022

SELL
$32.56 - $40.56 $1.39 Million - $1.73 Million
-42,683 Reduced 41.48%
60,224 $2.04 Million
Q4 2021

Feb 14, 2022

BUY
$36.93 - $42.14 $726,671 - $829,188
19,677 Added 23.64%
102,907 $4.34 Million
Q3 2021

Nov 15, 2021

BUY
$35.36 - $44.01 $2.94 Million - $3.66 Million
83,230 New
83,230 $3.4 Million
Q2 2021

Aug 13, 2021

SELL
$29.45 - $35.85 $1.67 Million - $2.04 Million
-56,843 Closed
0 $0
Q4 2020

Feb 09, 2021

SELL
$22.9 - $28.15 $469,449 - $577,075
-20,500 Reduced 26.51%
56,843 $1.6 Million
Q3 2020

Nov 16, 2020

BUY
$16.99 - $22.79 $782,355 - $1.05 Million
46,048 Added 147.14%
77,343 $1.74 Million
Q2 2020

Aug 06, 2020

BUY
$11.78 - $19.24 $368,655 - $602,115
31,295 New
31,295 $532,000
Q1 2020

May 14, 2020

SELL
$8.27 - $19.24 $217,567 - $506,165
-26,308 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$13.63 - $18.56 $629,596 - $857,323
-46,192 Reduced 63.71%
26,308 $477,000
Q3 2019

Nov 14, 2019

BUY
$13.85 - $19.18 $833,770 - $1.15 Million
60,200 Added 489.43%
72,500 $1.07 Million
Q2 2019

Aug 12, 2019

BUY
$14.5 - $19.09 $178,350 - $234,807
12,300 New
12,300 $235,000

Others Institutions Holding AVTR

About Avantor, Inc.


  • Ticker AVTR
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 674,035,008
  • Market Cap $15.5B
  • Description
  • Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulate...
More about AVTR
Track This Portfolio

Track Seven Eight Capital, LP Portfolio

Follow Seven Eight Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.